Full results of EndeavorRx adjunct trial show longer benefits with or without stimulant therapy

The digital therapeutic for children ' s ADHD symptoms received a De Novo clearance last summer.
Source: mobihealthnews - Category: Information Technology Tags: Digital Health, Life Sciences, Pharma, Technology, Care Source Type: news